Expression of Notch-1 and its clinical significance in different histological subtypes of human lung adenocarcinoma

Journal of Experimental and Clinical Cancer Research

Volumn 32, Issue 1, 2013, Pages

  Huang, Jiayuan ^a   Song, Haizhu ^a   Liu, Biao ^a   Yu, Bo ^a   Wang, Rui ^a   Chen, Longbang ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Histological subtypes; Immunohistochemistry; Lung adenocarcinoma; Notch 1; Prognosis

Indexed keywords

NOTCH1 RECEPTOR;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE RISK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTOR, NOTCH1;

EID: 84886157631     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-32-84     Document Type: Article

References (27)

1. Global cancer statistics. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, CA: A cancer journal for clinicians 2011 61 2 69 90 10.3322/caac.20107 21296855
2. Micropapillary lung adenocarcinoma: a distinctive histologic subtype with prognostic significance. Case series. Sánchez-Mora N, Presmanes MC, Monroy V, Moreno N, Lara-Martínez JM, Aladro MH, Álvarez- Fernández E, Human pathology 2008 39 3 324 330 10.1016/j.humpath.2007.05. 029 18261622 (Pubitemid 351186688)
3. Surgery on extracorporeal circulation in early and advanced non-small cell lung cancer. Kauffmann M, Kruger T, Aebert H, Thorac Cardiovasc Surg 2013 61 2 103 108 23212162
4. Small interference RNA targeting tissue factor inhibits human lung adenocarcinoma growth in vitro and in vivo. Xu C, Gui Q, Chen W, Wu L, Sun W, Zhang N, Xu Q, Wang J, Fu X, J Exp Clin Cancer Res 2011 30 63 10.1186/1756-9966-30-63 21619686
5. Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance. Ma Q, Li P, Xu M, Yin J, Su Z, Li W, Zhang J, J Exp Clin Cancer Res 2012 31 99 10.1186/1756-9966-31-99 23181744
6. Developmental signaling pathways in cancer stem cells of solid tumors. Karamboulas C, Ailles L, Biochim Biophys Acta 2013 1830 2 2481 2495 10.1016/j.bbagen.2012.11.008 23196196
7. The AKT1/NF-kappaB/Notch1/PTEN axis has an important role in chemoresistance of gastric cancer cells. Zhou W, Fu X, Zhang L, Zhang J, Huang X, Lu X, Shen L, Liu B, Liu J, Luo H, Cell Death & Disease 2013 4 10 847 10.1038/cddis.2013.375 24113181
8. Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo. Yu XM, Phan T, Patel PN, JaskulaSztul R, Chen H, Cancer 2013 119 4 774 781 10.1002/cncr.27742 22991264
9. Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survival. Donnem T, Andersen S, Al-Shibli K, Al-Saad S, Busund LT, Bremnes RM, Cancer 2010 116 24 5676 5685 10.1002/cncr.25551 20737536
10. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, et al. J Thorac Oncol 2011 6 2 244 285 10.1097/JTO.0b013e318206a221 21252716
11. Profiling immunohistochemical expression of NOTCH1-3, JAGGED1, cMET, and phospho-MAPK in 100 carcinomas of unknown primary. Krikelis D, Pentheroudakis G, Goussia A, Siozopoulou V, Bobos M, Petrakis D, Stoyianni A, Golfinopoulos V, Cervantes A, Ciuleanu T, Fountzilas G, Malamou-Mitsi V, Pavlidis N, Clin Exp Metastasis 2012 29 6 603 614 10.1007/s10585-012-9474-4 22526456
12. Review The Revised TNM Staging System for Lung Cancer. Rami-Porta R, Crowley JJ, Goldstraw P, Ann Thorac Cardiovasc Surg 2009 15 1 5
13. Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma. Jundt F, Acikgoz O, Kwon SH, Schwarzer R, Anagnostopoulos I, Wiesner B, Mathas S, Hummel M, Stein H, Reichardt HM, Dörken B, Leukemia 2008 22 8 1587 1594 10.1038/leu.2008.101 18449208
14. Prognostic impact of delta-like ligand 4 and Notch1 in acute myeloid leukemia. Zhang J, Ma D, Ye J, Zang S, Lu F, Yang M, Qu X, Sun X, Ji C, Oncol Rep 2012 28 4 1503 1511 22858860
15. Notch1 Promotes Glioma Cell Migration and Invasion by Stimulating βcatenin and NFκB Signaling via AKT Activation. Zhang X, Chen T, Zhang J, Mao Q, Li S, Xiong W, Qiu Y, Xie Q, Ge J, Cancer Sci 2012 103 2 181 190 10.1111/j.1349-7006.2011.02154.x 22093097
16. MicroRNA-34a Modulates Chemosensitivity of Breast Cancer Cells to Adriamycin by Targeting Notch1. Li XJ, Ji MH, Zhong SL, Zha QB, Xu JJ, Zhao JH, Tang JH, Arch Med Res 2012 43 7 514 521 10.1016/j.arcmed.2012.09.007 23085450
17. SIRT1 regulates endothelial Notch signaling in lung cancer. Xie M, Liu M, He CS, PLoS One 2012 7 9 45331 10.1371/journal.pone.0045331 23028940
18. Inhibition of ADAM-17 more effectively down-regulates the Notch pathway than that of gamma-secretase in renal carcinoma. Guo Z, Jin X, Jia H, J Exp Clin Cancer Res 2013 32 26 10.1186/1756-9966-32-26 23659326
19. Different patterns of NF-kappaB and Notch1 signaling contribute to tumor-induced lymphangiogenesis of esophageal squamous cell carcinoma. Su C, Chen Z, Luo H, Su Y, Liu W, Cai L, Wang T, Lei Y, Zhong B, J Exp Clin Cancer Res 2011 30 85 10.1186/1756-9966-30-85 21939555
20. Notch1 destabilizes the adherens junction complex through upregulation of the Snail family of E-cadherin repressors in non-small cell lung cancer. Kim A, Kim EY, Cho EN, Kim HJ, Kim SK, Chang J, Ahn CM, Chang YS, Oncology reports 2013 30 3 1423 1429 23807483
21. Notch signaling inhibits growth of the human lung adenocarcinoma cell line A549. Zheng Q, Qin H, Zhang H, Li J, Hou L, Wang H, Zhang X, Zhang S, Feng L, Liang Y, Han H, Yi D, Oncol Rep 2007 17 4 847 852 17342326
22. Notch-1 signaling facilitates survivin expression in human non-small cell lung cancer cells. Chen Y, Li D, Liu H, Xu H, Zheng H, Qian F, Li W, Zhao C, Wang Z, Wang X, Cancer biology & therapy 2011 11 1 14 21 10.4161/cbt.11.1.13730 20962575
23. Oxygen concentration determines the biological effects of NOTCH-1 signaling in adenocarcinoma of the lung. Chen Y, De Marco MA, Graziani I, Gazdar AF, Strack PR, Miele L, Bocchetta M, Cancer research 2007 67 17 7954 7959 10.1158/0008-5472.CAN-07-1229 17804701 (Pubitemid 47395124)
24. γ-Secretase Modulator in Alzheimer's Disease: Shifting the End. Xia W, Wong ST, Hanlon E, Morin P, J Alzheimers Dis 2012 31 4 685 696 22710916
25. A phase II study of RO4929097 in metastatic colorectal cancer. Strosberg JR, Yeatman T, Weber J, Coppola D, Schell MJ, Han G, Almhanna K, Kim R, Valone T, Jump H, Eur J Cancer 2012 48 7 997 1003 10.1016/j.ejca.2012.02.056 22445247
26. Notch1 is required for Kras-induced lung adenocarcinoma and controls tumor cell survival via p53. Licciulli S, Avila JL, Hanlon L, Troutman S, Cesaroni M, Kota S, Keith B, Simon MC, Puré E, Radtke F, Cancer research 2013 73 19 5974 5984 10.1158/0008-5472.CAN-13-1384 23943799
27. Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry. Kluk MJ, Ashworth T, Wang H, Knoechel B, Mason EF, Morgan EA, Dorfman D, Pinkus G, Weigert O, Hornick JL, PLoS One 2013 8 6 67306 10.1371/journal.pone.0067306 23825651